Moderna (NASDAQ: MRNA) has been a huge winner so far this year with its share price more than quadrupling. In this Motley Fool Live video recorded on Sept. 15, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether or not now is a good time to buy Moderna stock. Keith Speights: Bhakti asks, "Is it a good time to initiate a position in Moderna?" MRNA is the ticker there.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting